Ipca Laboratories Share Price | Nomura, in its brokerage note, said that its positive view on Ipca Laboratories stock is based on consistent outperformance in the domestic formulation market. The brokerage added that the company’s domestic formulation business attracts higher valuation multiples and will contribute as much as 50% to Ipca Laboratories’ earnings before interest taxes depreciation and amortisation (EBITDA) for FY26 and FY27.
